Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek]
Timothy grass pollen extract
RxCUI: 1495316
What the CMS Formulary Data Shows for Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek]
Per the CMS 2026 Part D formulary file, Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] (RxNorm concept RXCUI 1495316, generic name Timothy grass pollen extract) appears on 12 distinct formulary files spanning 189 Medicare Part D plan offerings - 3.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 4, with a cross-plan average of Tier 3.1.
Real-world access to Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] depends on utilization management as much as tier placement: 58.3% of covering formularies require prior authorization. 0% require step therapy. 16.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 170 Part D beneficiaries filled Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] in 2023, with total plan-and-beneficiary spending of $329,331 and an average per-beneficiary annual cost of $1,937.24. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] today.
Coverage Details
- Formularies covering
- 12
- Plans covering
- 189
- Coverage rate
- 3.7%
- Tier range
- Tier 2 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 58.3% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 16.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 170
- Total spending
- $329,331
- Avg per beneficiary
- $1,937.24
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] covered by Medicare Part D?
Yes, Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] is covered by 189 Medicare Part D plans (3.7% of all Part D formularies).
What tier is Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] on Medicare Part D plans?
Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] averages Tier 3.1 across Part D plans, ranging from Tier 2 to Tier 4.
Does Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] require prior authorization?
58.3% of Part D formularies require prior authorization for Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek]. Step therapy: 0%. Quantity limits: 16.7%.
How much does Medicare spend on Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek]?
In 2023, total Medicare Part D spending on Timothy grass pollen extract 2800 BAU Sublingual Tablet [Grastek] was $329,331, covering 170 beneficiaries. The average spend per beneficiary was $1,937.24.
Read our methodology - how this data is sourced, computed, and verified.